2013
DOI: 10.1088/1758-5082/5/3/035010
|View full text |Cite
|
Sign up to set email alerts
|

Fabrication of bioactive conduits containing the fibroblast growth factor 1 and neural stem cells for peripheral nerve regeneration across a 15 mm critical gap

Abstract: Nerve conduits are often used in combination with bioactive molecules and stem cells to enhance peripheral nerve regeneration. In this study, the acidic fibroblast growth factor 1 (FGF1) was immobilized onto the microporous/micropatterned poly (D, L-lactic acid) (PLA) nerve conduits after open air plasma treatment. PLA substrates grafted with chitosan in the presence of a small amount of gold nanoparticles (nano Au) showed a protective effect on the activity of the immobilized FGF1 in vitro. Different conduits… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
37
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(38 citation statements)
references
References 40 publications
0
37
0
1
Order By: Relevance
“…However, the only source of SCs is to sacrifice a healthy nerve (analogous to an autograft) and SCs do not seem to proliferate well under cell culture environments (28,29). In seeking alternatives, researchers are investigating other cell types for nerve regeneration strategies such as olfactory ensheathing cells (30,31,32,33), neural stem cells (34,35,36,37) and MSCs derived from various sources (bone marrow (38,39), adipose derived (38,40), These tMSCs were characterized and compared with undifferentiated MSCs (uMSCs) by immunostaining using glial markers such as α-S100β, α-p75 NTR and α-GFAP (8,13,45). Ladak et.al.…”
Section: Transdifferentiation Of Mscsmentioning
confidence: 99%
“…However, the only source of SCs is to sacrifice a healthy nerve (analogous to an autograft) and SCs do not seem to proliferate well under cell culture environments (28,29). In seeking alternatives, researchers are investigating other cell types for nerve regeneration strategies such as olfactory ensheathing cells (30,31,32,33), neural stem cells (34,35,36,37) and MSCs derived from various sources (bone marrow (38,39), adipose derived (38,40), These tMSCs were characterized and compared with undifferentiated MSCs (uMSCs) by immunostaining using glial markers such as α-S100β, α-p75 NTR and α-GFAP (8,13,45). Ladak et.al.…”
Section: Transdifferentiation Of Mscsmentioning
confidence: 99%
“…There are several clinical strategies to restore nerve function, including artificial chambers [11], neurotrophic factors [12], stem cells [13], and nerve grafting [14]. Despite the application of modern and advanced techniques for peripheral nerve injuries, functional outcomes are often unpredictable and disappointing.…”
Section: Discussionmentioning
confidence: 99%
“…And, at 0 min and 14 days after sciatic nerve injury, there was no any recovery of motor function. At 42 days after SNI, the SFI in SNI + COS group was better than in the SNI group and SNI + vehicle group (*p<0.05, **p<0.01, n= 8) 13.3×(EIT − NIT) / NIT−8.8. SFI is the sciatic nerve function index, E indicates the experimental (injured) foot, N indicates the normal foot, PL is the length from the tip of the toe to the heel, TS is the span between the first and fifth toes, and IT is the span between the second and fourth toes.…”
Section: Footprint Experimentsmentioning
confidence: 94%
“…Current literature evaluating CatWalk only employ a single injury group and a sham group, so to emulate current research practices, we employed three experimental groups, each receiving nerve resection injury followed by different interventions leading to different levels of recovery: one with an autologous nerve graft (clinical gold standard) to serve as positive control, one with an empty nerve conduit to serve as negative control, and one with human neural crest stem cell (NCSC) implantation to serve as the study target (Bozkurt et al, 2008), which leads to improvements in recovery that is superior to empty nerve conduits but not as effective as autologous nerve grafts (Georgiou et al, 2015; Ni et al, 2013; Wang et al, 2015). …”
Section: Introductionmentioning
confidence: 99%